<DOC>
	<DOCNO>NCT00000300</DOCNO>
	<brief_summary>The purpose study test therapeutic benefit take-home LAAM . ( 1 ) Do subject take-home LAAM availability show increase clinical responsibility subject without ; ( 2 ) Do subject take-home LAAM attempt diversion random recall diversion safeguard use ; ( 3 ) Does treatment response correlate background drug use variable intake , discharge , treatment ?</brief_summary>
	<brief_title>Feasibility Study Take-Home LAAM Medication - 3</brief_title>
	<detailed_description>1-Year study , participant randomly assign one two group : One opportunity earn take-home dos turn designated number clean urine . Two opportunity earn take-home dos . Clinic visit three time per week . Urine sample give visit .</detailed_description>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<criteria>meet DSMIV criterion opiate dependence . M/F , 18 year old . Certified LAAm treatment physician . Able understand english . Willing provide name , address , number 3 relative aid patient location followup visit . Hypertensive LAAM . Pregnant nursing woman . Female childbearing potential refuse use acceptable form birth control . Clinically significant abnormality hematology , blood work , UA , ETOH and/or sedative/hypnotic dependence accord DSMIV criterion . Medical psychiatric illness would jeopardize safe study participation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 1995</verification_date>
</DOC>